Table 2

Area under the receiver operating characteristic curves with 95% CI for each algorithm and each patient set

ACR/EULAR 2010Van der HelmVisser
Outcome methotrexate use
 UA patients0.79 (0.73 to 0.85)0.80 (0.74 to 0.87)0.83 (0.77 to 0.88)
 All patients0.79 (0.75 to 0.83)0.88 (0.84 to 0.91)0.80 (0.76 to 0.85)
Outcome persistent disease
 UA patients0.77 (0.71 to 0.85)0.78 (0.71 to 0.85)0.77 (0.71 to 0.83)
 All patients0.74 (0.70 to 0.78)0.83 (0.79 to 0.87)0.74 (0.70 to 0.79)
  • UA, undifferentiated arthritis.